Analysis

Precision Peptide Company Inc (BPC) Stock Analysis

Precision Peptide Company Inc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to BPC.

websiteBPC/analysis/BPC

Precision Peptide Company Inc

Precision Peptide Company Inc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to BPC.

Stock profile

Ticker

BPC

Asset type

Stock

Market cap

$9.5M

Sector

Consumer Services

Industry

Restaurants

Currency

CAD

Ticker listings

Precision Peptide Company Inc may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • BPC primary listing
  • PNGAF
  • XU0

Latest Precision Peptide Company Inc news

The Precision Peptide Company Achieves LegitScript Healthcare Merchant Certification

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness comp...

The Precision Peptide Company Announces Release of The Human Upgrade with Dave Asprey Episode Featuring Chief Scientific Officer Justin K...

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness comp...

The Precision Peptide Company Inc. Announces up to $2 Million LIFE Offering of Common Shares

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it i...

The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership

The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure

The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), is pleased to announce that, fur...

Research sections

Valuation

Review valuation context for Precision Peptide Company Inc.

Future growth

Review future growth context for Precision Peptide Company Inc.

Past performance

Review past performance context for Precision Peptide Company Inc.

Financial health

Review financial health context for Precision Peptide Company Inc.

Dividend

Review dividend context for Precision Peptide Company Inc.

Management

Review management context for Precision Peptide Company Inc.

Ownership

Review ownership context for Precision Peptide Company Inc.

Other information

Review other information context for Precision Peptide Company Inc.

Community

Review community context for Precision Peptide Company Inc.